Clinical trial · Interventional
Teleconference Group: Breast Cancer in African Americans (STORY)
Teleconference Group: Breast Cancer in African Americans
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
African American women with breast cancer have decreased quality of life (and mood when compared to European American. Research has not examined the effectiveness of therapeutic group for African American women with breast cancer even though positive effects are well established for Caucasians. The aims of the randomized clinical trial are to determine the effectiveness of TG by teleconference for African American women with breast cancer and what factors may impact on the intervention. The primary hypothesis is that participants in the intervention group will have significantly greater cancer knowledge, less fear, less isolation, better social connection, better mood, and better QOL when compared to a control group receiving usual psychosocial care. Two hundred forty African American women with breast cancer will be recruited. Intervention participants attend eight weekly 90 minute sessions by teleconference and two follow-up boosters. Each culturally appropriate session contains the story, information and group processes of connection, commonality and catharsis. Information focuses on increasing self care and stress management knowledge while countering myths and taboos. Story capitalizes on African American oral traditions by discussing coping parables. Group processes provide an alternative source of social support and opportunities to express feelings. Control group subjects receive standard psychosocial care (the use of any support programs or services locally or nationally. Testing will occur at baseline, after 10 group sessions and 16 weeks post baseline. The study findings are expected to inform about the effectiveness of therapeutic groups in African American women with breast cancer and lay the groundwork for exploring if reducing disparities in psychosocial care have a health benefit.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Therapeutic Group by Teleconference | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual Psychosocial Care
- description
- Participants are free to use any psychosocial care available to cancer patients. No restrictions to participation in other groups or services.
- type
- EXPERIMENTAL
- label
- Therapeutic Group by teleconference
- description
- ten 90 minute group sessions by teleconference. Lead by social workers. Sessions focus on information, story sharing and coping.
- interventionNames
- Behavioral: Therapeutic Group by Teleconference
Primary outcomes (1)
- measure
- Social connection
- timeFrame
- Participants are assessed at time one (baseline/pretest) and followed for 16 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * US born * African American women * age 21 or older * diagnosed with invasive/infiltrating ductal carcinoma * reside in South Carolina or the borders of North Carolina or Georgia Exclusion Criteria: * Non-english speaking * diagnosed with metastatic disease at diagnosis * have a major cognitive impairment * have a current diagnosis of psychosis * are undergoing concurrent treatment for another form of cancer (except basal cell or squamous cell of skin) * Participation in another behavioral trial
References
Publications (1)
- RESULTHeiney SP, Adams SA, Wells LM, Johnson H. Evaluation of conceptual framework for recruitment of African American patients with breast cancer. Oncol Nurs Forum. 2010 May;37(3):E160-7. doi: 10.1188/10.ONF.E160-E167. PMID 20439201